CSS
NXTM

Cubist Systematic Strategies’s NxStage Medical Inc. NXTM Stock Holding History

Cubist Systematic Strategies’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-400
Closed -$10K – 1986
2016
Q4 		$10K Buy
+400
New +$9.89K ﹤0.01% 1651
2016
Q2 		– Sell
-6,223
Closed -$93K – 1984
2016
Q1 		$93K Sell
6,223
-5,263
-46% -$88.2K 0.01% 1409
2015
Q4 		$252K Sell
11,486
-7,380
-39% -$138K 0.01% 1222
2015
Q3 		$298K Sell
18,866
-17,821
-49% -$286K 0.02% 1239
2015
Q2 		$524K Buy
36,687
+20,440
+126% +$346K 0.03% 938
2015
Q1 		$281K Buy
16,247
+13,003
+401% +$230K 0.01% 1298
2014
Q4 		$58K Buy
3,244
+3,148
+3,279% +$50.7K ﹤0.01% 1765
2014
Q3 		$1K Sell
96
-2,846
-97% -$38.3K ﹤0.01% 1717
2014
Q2 		$42K Buy
+2,942
New +$38.4K ﹤0.01% 1418

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cubist Systematic Strategies's NXTM Position: Q1 2017 in Review

Cubist Systematic Strategies sold out of NxStage Medical Inc. (NXTM) in Q1 2017, closing a stake of 400 shares — an estimated $10K sold.

Cubist Systematic Strategies first reported a position in NXTM in Q2 2014 and held it in 9 quarters. The position peaked at $524K in Q2 2015. 171 funds tracked by Wall St. Rank hold NXTM as of Q1 2017.

  • Cubist Systematic Strategies reported no remaining NxStage Medical Inc. position as of Q1 2017 after selling out during the quarter.
  • Cubist Systematic Strategies sold 400 NxStage Medical Inc. shares in Q1 2017, an estimated $10K.
  • Cubist Systematic Strategies first reported a position in NxStage Medical Inc. in Q2 2014 and held it in 9 quarters.
  • Cubist Systematic Strategies's NxStage Medical Inc. position peaked at $524K in Q2 2015.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2017.

Based on Cubist Systematic Strategies's 13F filing for Q1 2017, filed 15 May 2017.